Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant population

Published:2022-11 Issue: Volume:175 Page:246-253
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Vic Samuel^ORCID,Lemoine Jean,Armand Philippe^ORCID,Lemonnier François,Houot Roch^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference58 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-hodgkin’s lymphoma;Philip;N Engl J Med,1995

2. Influence of age and histology on outcome in adult non-hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the center for international blood & marrow transplant Research (CIBMTR);Lazarus;Biol Blood Marrow Transplant,2008

3. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Tilly;Ann Oncol,2015

4. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

5. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CARs moving forward: The development of CAR T-cell therapy in the earlier treatment course of hematologic malignancies;Seminars in Hematology;2024-08

2. Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma;Frontiers in Oncology;2024-07-19

3. License for a CAR T: Examining patient eligibility;Seminars in Hematology;2024-07

4. Appropriate Treatment Intensity for Diffuse Large B-Cell Lymphoma in the Older Population: A Review of the Literature;Hematology Reports;2024-05-24

5. Epidemiology and Real-World Treatment of Incident Diffuse Large B-cell Lymphoma (DLBCL): A German Claims Data Analysis;Oncology and Therapy;2024-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3